Abigail Gregor Featured in Bloomberg Law “They’ve Got Next: 40 Under 40” Series
Life sciences licensing partner Abigail Gregor was honored in Bloomberg Law’s “They’ve Got Next: 40 Under 40” in the Healthcare and Life Sciences category. The Bloomberg Law series features attorneys under the age of 40 who are doing consequential work in their practice areas.
In the profile article, Abigail describes some of her most substantial legal work including representing Blackstone in its $2 billion financing collaboration with Alnylam - a complex transaction with multiple deals rolled into one (a royalty monetization, a product financing, an equity component, and a debt component)—all on an expedited timeline. She also cited her work for ImmunoGen in its worldwide exclusive license with Eli Lilly for up to $1.7 billion under ImmunoGen’s novel technology to advance antibody-drug conjugates directed to certain Lilly-selected targets.